Ellen Wientjens

4.4k citations

18 papers · 3.3k indexed · 2 hit papers · h-index 17

Co-authors: Maarten van Lohuizen Rob Michalides Anton Berns Rob Klompmaker Renate M.L. Zwijsen Sjef Verbeek René Bernards Jos Jonkers
Topics: Epigenetics and DNA Methylation (4 papers)Cancer-related Molecular Pathways (4 papers)Cancer Mechanisms and Therapy (3 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: Nature Cell Nature Communications
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Ellen Wientjens

17 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging

1991 640 citations Maarten van Lohuizen, Sjef Verbeek et al. Cell profile →
CDK-Independent Activation of Estrogen Receptor by Cyclin D1

1997 607 citations Renate M.L. Zwijsen, Ellen Wientjens et al. Cell profile →

Peers

Countries citing papers authored by Ellen Wientjens

Since Specialization

Citations

This map shows the geographic impact of Ellen Wientjens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Wientjens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Wientjens more than expected).

Fields of papers citing papers by Ellen Wientjens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Wientjens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Wientjens. The network helps show where Ellen Wientjens may publish in the future.

Co-authorship network of co-authors of Ellen Wientjens

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Wientjens. A scholar is included among the top collaborators of Ellen Wientjens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Wientjens. Ellen Wientjens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3 2025 ·Cancer Research ·(unknown),Jinhyuk Bhin,Eline van der Burg,Anne Paulien Drenth,(unknown),Catrin Lutz,(unknown),Ellen Wientjens,Sjoerd Klarenbeek,(unknown),(unknown),Stefano Annunziato,Natalie Proost,Bjørn Siteur,(unknown),Marieke van de Ven,(unknown),Shridar Ganesan,(unknown),Daniel Zingg,(unknown)	0
2	CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer 2023 ·Nature Communications ·Julia M. Houthuijzen,Roebi de Bruijn,Eline van der Burg,Anne Paulien Drenth,Ellen Wientjens,(unknown),(unknown),Chiara Svetlana Brambillasca,Emilia M. Pulver,Marja Nieuwland,Iris de Rink,(unknown),Sjoerd Klarenbeek,Ron Kerkhoven,Valerie G. Brunton,Colinda L. G. J. Scheele,Mirjam C. Boelens,Jos Jonkers	63
3	Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547 2018 ·Cancer Research ·Sjors M. Kas,Julian R. de Ruiter,Koen Schipper,Eva Schut,Lorenzo Bombardelli,Ellen Wientjens,Anne Paulien Drenth,Renske de Korte‐Grimmerink,Sunny Mahakena,Christopher Phillips,Paul Smith,Sjoerd Klarenbeek,Koen van de Wetering,Anton Berns,Lodewyk F.A. Wessels,Jos Jonkers	30
4	PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma 2016 ·Cell Reports ·Mirjam C. Boelens,Micha Nethe,Sjoerd Klarenbeek,Julian R. de Ruiter,Eva Schut,Nicola Bonzanni,Amber L. Zeeman,Ellen Wientjens,Eline van der Burg,Lodewyk F.A. Wessels,Renée van Amerongen,Jos Jonkers	37
5	A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants 2013 ·Cancer Discovery ·Peter Bouwman,Hanneke van der Gulden,Ingrid van der Heijden,Rinske Drost,Christiaan Klijn,Pramudita R. Prasetyanti,Mark Pieterse,Ellen Wientjens,Jost Seibler,Frans B.L. Hogervorst,Jos Jonkers	92
6	Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool 2013 ·Stem Cells ·Ewa M. Michalak,Karim Nacerddine,Alexandra M Pietersen,Vincent Beuger,Inka Pawlitzky,Paulien Cornelissen‐Steijger,Ellen Wientjens,Ellen Tanger,Jost Seibler,Maarten van Lohuizen,Jos Jonkers	36
7	Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors 2012 ·Cancer Discovery ·Janneke E. Jaspers,Ariena Kersbergen,Ute Boon,Wendy Sol,Liesbeth van Deemter,Serge A.L. Zander,Rinske Drost,Ellen Wientjens,Jiuping Ji,(unknown),James H. Doroshow,Aaron Cranston,Niall M.B. Martin,Alan Lau,Mark J. O’Connor,Shridar Ganesan,Piet Borst,Jos Jonkers,Sven Rottenberg	388
8	BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance 2011 ·Cancer Cell ·Rinske Drost,Peter Bouwman,Sven Rottenberg,Ute Boon,Eva Schut,Sjoerd Klarenbeek,Christiaan Klijn,Ingrid van der Heijden,Hanneke van der Gulden,Ellen Wientjens,Mark Pieterse,Aurélie Catteau,Peter Green,Ellen Solomon,Joanna R. Morris,Jos Jonkers	197
9	Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice 2002 ·Nature Genetics ·Anders H. Lund,(unknown),(unknown),Els Verhoeven,Ellen Wientjens,Danielle Hulsman,Robert G. Russell,Ronald A. DePinho,Jack Lenz,Maarten van Lohuizen	188
10	Interaction of Mouse Polycomb-Group (Pc-G) Proteins Enx1 and Enx2 with Eed: Indication for Separate Pc-G Complexes 1998 ·Molecular and Cellular Biology ·Maarten van Lohuizen,(unknown),Jan Willem Voncken,Armin Schumacher,Terry Magnuson,Ellen Wientjens	110
11	CDK-Independent Activation of Estrogen Receptor by Cyclin D1breakdown → 1997 ·Cell ·Renate M.L. Zwijsen,Ellen Wientjens,Rob Klompmaker,(unknown),René Bernards,Rob Michalides	607
12	A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer 1996 ·British Journal of Cancer ·Rob Michalides,P Hageman,Harm van Tinteren,(unknown),Ellen Wientjens,Rob Klompmaker,Johannes L. Peterse	154
13	Cyclin D1 Triggers Autonomous Growth of Breast Cancer Cells by Governing Cell Cycle Exit 1996 ·Molecular and Cellular Biology ·Renate M.L. Zwijsen,Rob Klompmaker,Ellen Wientjens,Petra Kristel,Bart van der Burg,Rob Michalides	115
14	Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. 1995 ·PubMed ·Rob Michalides,(unknown),(unknown),Barbara Loftus,Ellen Wientjens,A. J. M. Balm	301
15	Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2 1991 ·Nature ·Maarten van Lohuizen,Manfred Frasch,Ellen Wientjens,Anton Berns	206
16	Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. 1991 ·PubMed ·M. Breuer,Ellen Wientjens,Sjef Verbeek,Robert J.C. Slebos,A Berns	62
17	Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus taggingbreakdown → 1991 ·Cell ·Maarten van Lohuizen,Sjef Verbeek,(unknown),Ellen Wientjens,(unknown),Anton Berns	640
18	Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice 1989 ·Nature ·Marco L. Breuer,Robert J.C. Slebos,Sjef Verbeek,Maarten van Lohuizen,Ellen Wientjens,Anton Berns	116

About Ellen Wientjens

Ellen Wientjens is a scholar working on Oncology, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 18 papers that have together received 3.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Oncology (1.8k citations), Molecular Biology (2.4k citations) and Cancer Research (420 citations). Ellen Wientjens has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Maarten van Lohuizen, Rob Michalides, Anton Berns, Rob Klompmaker, Renate M.L. Zwijsen, Sjef Verbeek, René Bernards, Jos Jonkers, Manfred Frasch and A. J. M. Balm. Their work appears in journals such as Nature, Cell and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact